Training courses & Webinars:
Biopharma

Biopharmaceuticals, known colloquially as biopharma, are the point at which biotechnology and pharmaceutical manufacturing meet. Biopharma is the application of living organisms or extractions, by-products or components of living organisms, to prevent, relieve, or treat diseases.

Management Forum’s biopharma training courses provide an extensive series of training opportunities covering a variety of topics, including the development of biopharmaceuticals, clinical trial requirements, manufacture, regulations and applicable standards. Our courses also provide insight into the use of emerging technologies and state-of-the-art processes.  

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Biosimilars Training Course

Biosimilars

30-31 Jan 2025 - Online webinar
Also on: 21 May 2025

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

Presented by Andrew Willis (bio)

More @ IPI Academy

Biotechnology for the Non-Biotechnologist Training Course

Biotechnology for the Non-Biotechnologist

2-6 Dec 2024 - Online webinar

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Presented by Robert Alvarez (bio)
and 6 more leading experts

More @ IPI Academy

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products Training Course

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

27-28 Feb 2025 - Online webinar
Also on: 26 Jun 2025

The regulatory requirements for Biological drug products are complex, and pharmaceutical companies are continuously under pressure to ensure regulatory compliance from drug discovery to post-marketing surveillance.
This course has been designed to help you navigate the complex regulatory requirements for biological drugs, including ATMPs. It will clearly depict the differences between small and large molecules and the development approaches which reflect the type of molecule. It will address the key aspects of the CTD, look at the CMC regulatory requirements during different stages of development, and discuss the importance of change control.

Presented by Andrew Willis (bio)

More @ IPI Academy

US FDA (Food and Drug Administration) - Understanding Key Factors When Working with the FDA (Food and Drug Administration) Training Course

US FDA - Understanding Key Factors When Working with the FDA

27 Nov 2024 - Online webinar
Also on: 13 Mar 2025

This course has been designed to provide an essential overview of the critical factors when working with the FDA (Food and Drug Administration).  For those short on time this course is for you, as you will receive a focused and comprehensive overview of the key strategic considerations when making applications to the FDA.  

Presented by Andrew Willis (bio)

More @ IPI Academy

In-house training

We can provide any of our courses on an in-house basis - at your location or online, with a programme and presenters tailored to your exact requirements. If you require training for multiple staff members, contact us to see how we can work with you.

Previous attendees said...

“Excellent, I am so please a colleague mentioned to IPI to me. ”

Julie Bailey, CFO, ILC Therapeutics Ltd

“Content flow is well designed and good. [Parts I particularly liked were] process economy , Upstream and Downstream scale up.”

Arindam Gupta, Global Category Procurement Manager, Servier Monde

“I wanted to get short insight into biosimilar development process and I completely accomplished it. ”

Ainars Gavarans, , Olainfarm AS

“Content was informative, I've learned many new details and subjects to consider. Speaker was fluent and interactive. I'll recommend this course to new QP's in the future. ”

Lian Abu-Obed, QP Trainee, Unipharm Limited

“The speaker had lots of clarity in his explanations, making the course very easy to follow and understand, even with deep topics.”

Bernardo Diaz, Regulatory Affairs Manager, Bioeq AG

“I thought all the speakers were excellent. You could tell that they all really knew there subject matter and were so passionate in the way they delivered the content. Special mention has to go to Adekunle - fantastic course leader and so knowledgeable and made the 3 days very interactive.”

Mark Kalinowski, Chief Financial officer, Albumedix Ltd

“Good webinar, presentation and excellent speakers”

Nor Hazwan Ali, Head of Regulatory Affairs,

“The course was good and it was a pleasure to learn from the speakers. I wanted to get an overview of research and development of drugs and pharmaceuticals. I think this was achieved. ”

Sarah Kanna, Senior Legal Associate, Hevolution Foundation

“ It felt comprehensive.
An excellent resource going forward.”

James McCracken, Quality Audit Manager , Advanz Pharma

“Webinar was good, informative and lots of information. Speakers are well knowledgeable about Biosimilar Industry.”

Srikanth Varma Kc, Global Audit and Due Diligence QA Manager, Abbott